Relationship between cachexia and perineural invasion in pancreatic adenocarcinoma

doi:10.4251/wjgo.v11.i12.1126

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 12

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6411)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-4) series.

Item

Count

PDF

373

WORD

208

HTML

2991

Figures (1-5)

276

Tables (1-4)

261

Sum=4109

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

907

Download

1395

Sum=2302

Dec 15, 2019 (publication date) through Dec 28, 2024

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Control Study

World J Gastrointest Oncol. Dec 15, 2019; 11(12): 1126-1140
Published online Dec 15, 2019. doi: 10.4251/wjgo.v11.i12.1126

Table 2 Protein plasma expression in adenocarcinoma patients and interaction with clinical and biological parameters, n (%)

Protein expression	Midkine		Activin
Protein expression	Low (n = 60)	High (n = 54)	Low (n = 42)	High (n = 72)
Age (yr), mean (SD)	63.02 (10.06)	66.7 (10.91)	63.64 (10.4)	65.42 (10.7)
BMI (kg/m²), median (IQR)	24.34 (20.71-26.54)	25.79 (23.11-27.52)^a	25.66 (22.24-27.52)	24.52 (22.05-26.94)
CA 19-9 (U/mL), median (IQR)	400 (53.5-400)	352 (70-400)	400 (53.5-400)	191 (70-400)
Age > 50 yr	53 (88.33)	50 (92.59)	36 (85.71)	67 (93.06)
Sex (female)	27 (45)	20 (37.04)	18 (42.86)	29 (40.28)
Stage (III-IV vs I-II)	28 (46.67)	39 (72.22)^b	20 (47.62)	47 (65.28)
Histological grade
G1	3 (16.67)	4 (17.39)	3 (16.67)	4 (17.39)
G2	10 (55.56)	12 (52.17)	13 (72.22)	9 (39.13)
G3	5 (27.78)	7 (30.43)	2 (11.11)	10 (43.48)
Metastasis	20 (33.33)	28 (51.85)^a	14 (33.33)	34 (47.22)
Tumor size ≥ 3 cm	44 (78.57)	43 (87.76)	30 (75)	57 (87.69)
Weight loss of 5% over the past 6 mo	45 (90)	29 (82.86)	11 (26)	23 (32)
Weight
Underweight	9 (15)	3 (5.56)	3 (7.14)	9 (12.5)
Normal	28 (46.67)	20 (37.04)	16 (38.1)	32 (44.44)
Overweight	15 (25)	22 (40.74)	14 (33.33)	23 (31.94)
Obesity	8 (13.33)	9 (16.67)		8 (11.11)
Smoking	32 (53.33)	18 (33.33)^a	17 (40.48)	33 (45.83)
New-onset diabetes	16 (26.67)	8 (14.81)	8 (19.05)	16 (22.22)
Long-term diabetes	6 (10)	18 (33.33)^b	10 (23.81)	14 (19.44)
Diabetes	22 (36.67)	27 (50)	18 (42.86)	31 (43.06)
IHC
Negative	36 (60)	22 (40.74)^a	29 (69.05)	26 (36.11)^b
Weak	18 (30)	16 (29.63)	11 (26.19)	42 (58.33)
Moderate	5 (8.33)	11 (20.37)	2 (4.76)	4 (5.56)
Strong	1 (1.67)	5 (9.26)
Immunohistochemistry perineural invasion (appearances on slide)	2: 3 (9.09); 0: 17 (51.52); 1: 13 (39.39)	2: 9 (32.14)^a; 0: 7 (25); 1: 12 (42.86)	2: 5 (17.86); 0: 13 (46.43); 1: 10 (35.71)	2: 7 (21.21); 0: 11 (33.33); 1: 15 (45.45)
Cachexia	16 (73)	6 (27)	15 (26)	7 (32)

^aP < 0.05,

^bP < 0.01. BMI: Body-mass index; CA 19-9: Carbohydrate antigen; IHC: Immunohistochemistry; IQR: Interquartile range; CI: Confidence interval.

Citation: Petrusel L, Rusu I, Leucuta DC, Seicean R, Suharoschi R, Zamfir P, Seicean A. Relationship between cachexia and perineural invasion in pancreatic adenocarcinoma. World J Gastrointest Oncol 2019; 11(12): 1126-1140
URL: https://www.wjgnet.com/1948-5204/full/v11/i12/1126.htm
DOI: https://dx.doi.org/10.4251/wjgo.v11.i12.1126